Forbes: 3 Timeless Lessons Every Investor Can Learn From Valeant Pharmaceuticals' Crash
Click here to read the full story:
http://www.forbes.com/sites/adamsarhan/2016/03/15/3-lessons-from-valeant-pharmaceuticals-crash/#191ec0213293
Similar Posts
Adam Sarhan IBTimes Quote: Citgroup Inc (C) Q2 Earnings Preview 2013
Citgroup Inc (C) Q2 Earnings Preview 2013: Many Predict Good Results, But Some Doubts Remain Over Their Large International Businesses By Christopher Harress on July 12 2013 1:38 PM Citigroup Inc. (NYSE:C) is expected to report a 16.2 percent increase on second-quarter profits as its investment banking and securities division look forward to sharp…
Sarhan in CNBC: Stocks slightly higher as oil rises; transports struggle for gains
Thursday, May 5, 2016 9:45am U.S. stocks traded higher Thursday as higher oil prices supported a more risk-on tone, ahead of the key employment report due Friday. “It’s a little bit of a relief rally … oversold bounce,” said Adam Sarhan, CEO of Sarhan Capital. “You also have a rebound in oil which is very…
Reuters: S&P 500 slips back into the red for the year
Markets | Thu Dec 31, 2015 11:40am EST Wall Street was lower on Thursday, with the S&P 500 set to end the year with a small loss as energy stocks took a hit from a plunge in crude oil. Trading volumes are expected to be thin on the last day of the year, with traders…
Adam Sarhan Reuters Quote: Commodity traders more cautious than optimistic on QE3
By Barani Krishnan Thu Sep 13, 2012 8:04pm EDT (Reuters) – For commodity markets, the third iteration of U.S. central bank stimulus may play like many movie sequels — a familiar plot, a predictable rise, yet less potent than the original. But the Federal Reserve has introduced a new twist on its latest round of…
Tuesday Recap: Sarhan in CNBC: Stocks Fall As Dollar Jumps To Highest Level In Nearly 2 Months
Tuesday, October 04, 2016 U.S. stocks fell on Tuesday as investors digested a rising dollar, data from the International Monetary Fund, remarks from a Federal Reserve official and kept an eye on the latest developments from Deutsche Bank. “You’ve got two schools of thought here. You have momentum traders buying dips but you also have…
Sarhan in CNBC: Bulls vs bears – Two arguments for stocks in the second half
Stocks have been flat for 18 months, but some market participants see potential upside in the second half despite many reasons to doubt the staying power of this weeks’ gains. After Thursday’s close, the Dow Jones industrial average and the S&P 500 were virtually unchanged for the year, having gained just 2.69 percent and 2.90…
